NexgenRx Announces Option Grants

Toronto, Ontario (FSCwire) - NEXGENRX INC. ("NexgenRx" or the "Company") announces the grant to certain directors, officers and employees of NexgenRx of an aggregate of 2,625,000 options to acquire common shares in the capital of NexgenRx at a price of $0.23 for a period of 10 years (vesting as to 33.3% each year for three years, beginning on the first anniversary of the grant date).  The foregoing grant of options is subject to final regulatory approval.  All of the options granted today (and the common shares issuable upon exercise) will be subject to applicable securities law hold periods.

About NexgenRx

NexgenRx is Canada's only independent full service claims adjudicator with full front end administration capability. These combined capabilities allow NexgenRx to provide complete solutions to plan sponsors that need sophisticated health benefit technology applications, in a cost- effective manner. NexgenRx is committed to building partnerships with organizations looking to exceed the expectations of their clients and deliver superior administration and claims processing solutions at a competitive cost. More information on NexgenRx can be found at www.nexgenrx.com.  

Caution Regarding Forward-Looking Statements – This news release contains certain forward looking statements, including statements regarding the business and anticipated financial performance of the Corporation. These statements are subject to a number of risks and uncertainties. Actual results may differ materially from results contemplated by the forward-looking statements. When relying on forward-looking statements to make decisions, investors and others should carefully consider the foregoing factors and other uncertainties and should not place undue reliance on such forward-looking statements.

Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of the release.

FOR FURTHER INFORMATION PLEASE CONTACT:

To view this press release as a PDF file, click onto the following link:
public://news_release_pdf/NEXGENRX09292017.pdf

Source: NexgenRx Inc. (TSX Venture:NXG)

To follow NexgenRx Inc. on your favorite social media platform or financial websites, please click on the icons below.

Maximum News Dissemination by FSCwire. http://www.fscwire.com

Copyright © 2017 Filing Services Canada Inc.